NGNE
Neurogene Inc.Healthcare$19.76
▲ Bullish
Mkt Cap: $307.8M|Float: 5.1M|SI: 76.3%|DTC: 18.9
Data as of market close Mar 30, 2026
IV Rank
100
IV Pctl
86%
HV 20d
7177.0%
52W Range
$7-$37
ATR(14)
$1.67
Exp. Move
±25.1%
P/C Ratio
0.32
Earnings
May 7
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 18 | ±$4.95 | ±25.1% | $14.81 | $24.71 |
| 2026-06-18 | 80 | ±$4.40 | ±22.3% | $15.36 | $24.16 |
| 2026-09-18 | 172 | ±$5.70 | ±28.8% | $14.06 | $25.46 |
| 2027-01-15 | 291 | ±$15.65 | ±79.2% | $4.11 | $35.41 |
Explore NGNE options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.